|
⚲
|
| Keyboard |
| Degnan Chris
✚
|
|
|---|---|
| CIK # | 0001741968 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001741968] | |
| 4 | [0001741968] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| UroGen Pharma Ltd | |
| Degnan Chris | |
| Galera Therapeutics Inc | |
| Verrica Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
UroGen Pharma Ltd URGN
Restricted Stock Units · derivative
|
2026-01-31 | Grant | 32,609 | $0.00 | |
|
UroGen Pharma Ltd URGN
Ordinary Shares
|
2025-10-08 | Sell | 2,203 | $16.85 | 37,121 |
|
UroGen Pharma Ltd URGN
Restricted Stock Units · derivative
|
2025-10-08 | Option exercise | 4,483 | $0.00 | |
|
UroGen Pharma Ltd URGN
Ordinary Shares
|
2025-10-08 | Option exercise | 4,483 | ||
|
UroGen Pharma Ltd URGN
Employee Stock Option (right to buy) · derivative
|
2024-10-08 | Grant | 74,142 | $0.00 | |
|
UroGen Pharma Ltd URGN
Restricted Stock Units · derivative
|
2024-10-08 | Grant | 13,450 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Common Stock
|
2023-03-13 | Buy | 10,000 | $1.96 | 19,600 |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2023-02-25 | Grant | 185,000 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2022-02-28 | Grant | 135,000 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Grant | 82,500 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2020-01-31 | Grant | 74,435 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option · derivative
|
2019-11-06 | Grant | 229,513 | $0.00 | |
|
Verrica Pharmaceuticals Inc VRCA
Employee Stock Option (Right to Buy) · derivative
|
2019-02-28 | Grant | 44,000 | $0.00 | |
|
Verrica Pharmaceuticals Inc VRCA
Common Stock
|
2018-06-19 | Buy | 3,000 | $15.00 | 45,000 |